Does AMLODIPINE Cause Hypervolaemia? 122 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Hypervolaemia have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.2% of all adverse event reports for AMLODIPINE.
122
Reports of Hypervolaemia with AMLODIPINE
0.2%
of all AMLODIPINE reports
1
Deaths
98
Hospitalizations
How Dangerous Is Hypervolaemia From AMLODIPINE?
Of the 122 reports, 1 (0.8%) resulted in death, 98 (80.3%) required hospitalization, and 63 (51.6%) were considered life-threatening.
Is Hypervolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 122 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE Cause?
Hypotension (6,504)
Toxicity to various agents (5,554)
Completed suicide (5,267)
Drug ineffective (4,091)
Dyspnoea (3,907)
Dizziness (3,536)
Intentional overdose (3,427)
Fall (3,215)
Fatigue (3,141)
Headache (2,907)
What Other Drugs Cause Hypervolaemia?
TREPROSTINIL (580)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (428)
AMBRISENTAN (205)
MACITENTAN (202)
FUROSEMIDE (139)
CYCLOPHOSPHAMIDE (118)
SACUBITRIL\VALSARTAN (115)
TACROLIMUS (100)
PREDNISONE (98)
MYCOPHENOLATE MOFETIL (89)
Which AMLODIPINE Alternatives Have Lower Hypervolaemia Risk?
AMLODIPINE vs AMLODIPINE BESILATE
AMLODIPINE vs AMLODIPINE\ATORVASTATIN
AMLODIPINE vs AMLODIPINE\BENAZEPRIL
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL